Causes and consequences of hyperhomocyst(e)inemia

International Journal for Vitamin and Nutrition Research

Volumn 67, Issue 5, 1997, Pages 389-395

  Pietrzik, Klaus ^a   Brönstrup, Anja ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Classification; Etiology; Homocyst(e)ine; Hyperhomocyst(e)inemia; Prevalence

Indexed keywords

HOMOCYSTEINE;

AGED; ARTICLE; BLOOD; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; HUMAN; PREVALENCE;

AGED; AGED, 80 AND OVER; AMINO ACID METABOLISM, INBORN ERRORS; HOMOCYSTEINE; HUMANS; PREVALENCE;

EID: 1842404743     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Boushey, C. J., Beresford, S. A. A., Omenn, G. S. and Motulsky, A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274, 1049-1057.
2. Mölgaard, J., Malinow, M. R., Lassvik, C., Holm, A.-C., Upson, B. and Olsson, A. G. (1992) Hyperhomocyst(e)inaemia: an independant risk factor for intermittent claudication. J. Intern. Med. 231, 173-179.
3. 12 concentrations and risk for early-onset coronary artery disease. Am. J. Clin. Nutr. 59, 940-948.
4. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B. and Graham, I. (1991) Hyperhomocysteinemia: an independant risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155.
5. Ubbink, J. B., Delport, R. and Vermaak, W. J. H. (1996) Plasma homocysteine concentrations in a population with a low coronary heart disease prevalence. J. Nutr. 126, 1254S-1257S.
6. Kang, S.-S., Wong, P. W. K. and Malinow, M. R. (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Ann. Rev. Nutr. 12, 279-298.
7. Ubbink, J. B., Becker, P. J., Vermaak, W. J. H. and Delport, R. (1995) Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin. Chem. 41, 1033-1037.
8. Stabler, S. P., Marcell, P. D., Podell, E. R., Allen, R. H., Savage, D. G. and Lindenbaum, J. (1988) Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography- mass spectrometry. J. Clin. Invest. 81, 466-474.
9. Selhub, J., Jacques, P. F., Wilson, P. W. F., Rush, D. and Rosenberg, I. H. (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693-2698.
10. Verhoef, P. (1996) Homocysteine, B-vitamins and cardiovascular disease. In: Ph. D.-thesis, Dept. of Epidemiology and Public Health, Agricultural University, Wageningen, The Netherlands.
11. Ueland, P. M., Refsum, H., Stabler, S. P., Malinow, M. R., Andersson, A. and Allen, R. H. (1993) Total homocysteine in plasma or serum: Methods and clinical applications. Clin. Chem. 39, 1764-1779.
12. Ubbink, J. B., Vermaak, W. J. H., van der Merwe, A., Becker, P. J., Delport, R. and Potgieter, H. C. (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124, 1927-1933.
13. Van der Put, N., Steegers-Theunissen, R. P. M., Frosst, P., Trijbels, F. J. M., Eskes, T. K. A. B., van den Heuvel, L. P., Mariman, E. C. M., den Heyer, M., Rozen, R. and Blom, H. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346, 1070-1071.
14. Kang, S.-S., Wong, P. W. K., Zhou, J., Sora, J., Lessick, M., Ruggie, N. and Grcevich, G. (1988) Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 37, 611-613.
15. Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuvel, L. P. and Rozen, R. (1995) Acandidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase. Nature Genetics 10, 111-113.
16. Engbersen, A. M. T., Franken, D. G., Boers, G. H. J., Stevens, E. M. B., Trijbels, F. J. M. and Blom, H. J. (1995) Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am. J. Hum. Genet. 56, 142-150.
17. Kluijtmans, L. A. J., van den Heuvel, L. P. W. J., Boers, G. H. J., Frosst, P., Stevens, E. M. B., van Oost, B. A., den Heijer, M., Trijbels, F. J. M., Rozen, R. and Blom, H. J. (1996) Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 58, 35-41.
18. Ueland, P. M. and Refsum, H. (1989) Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 114, 473-501.
19. Chauveau, P., Chadefaux, B., Coude, M., Aupetit, J., Hannedouche, T., Kamoun, P. and Jungers, P. (1993) Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney International 43, S72-S77.
20. Stampfer, M. J., Malinow, M. R., Willett, W. C., Newcorner, L. M., Upson, B., Ullmann, D., Tishler, P. V. and Hennekens, C. H. (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US Physicians. JAMA 268, 877-881.
21. Guttormsen, A. B., Ueland, P. M., Nesthus, I., Nygard, O., Schneede, J., Vollset, S. E. and Refsum, H. (1996) Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μmol/Liter). J. Clin. Invest. 98, 2174-2183.
22. Thalhammer, O. (1975) Frequency of inborn errors of metabolism, especially PKU, in some representative newborn screening centers around the world. A collaborative study. Humangenetik 30, 273-286.
23. Mudd, S. H., Levy, H. L. and Skovy, F. (1995) Disorders of transsulfuration. In: The metabolic and molecular bases of inherited disease (Scriver, C.R., Beaudet, A.L., Sly, W. and Valle, D., eds.) pp. 1279-1238. McGraw Hill, New York, N Y.
24. Kang, S. (1996) Treatment of hyperhomocysteinemia: physiological basis. J. Nutr. 126, 1273S-1275S.
25. Whitehead, A. S., Gallagher, P., Mills, J. L., Kirke, P. N., Burke, H., Molloy, A. M., Weir, D. G., Shields, D. C. and Scott, J. M. (1995) A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med. 88, 763-766.
26. Sheppard, C. A., Goulding C. W. and Matthews, R. G. (1996) Biochemistry and molecular biology of 5,10-methylenetetrahydrofolate reductase and methionine synthase. In: Disorders of homocysteine metabolism: from rare genetic defects to common risk factors (November 20-22), Fulda, Germany.
27. Rees, M. M. and Rodgers, G. M. (1993) Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thrombosis Research 71, 337-359.
28. Wilcken, D. E. L., Wilcken, B., Dudman, N. P. B. and Tyrrell, P. A. (1983) Homocystinuria - the effects of betaine in the treatment of patients not responsive to pyridoxine. N. Engl. J. Med. 309, 448-453.
29. Finkelstein, J. D. (1990) Methionine metabolism in mammals. J. Nutr. Biochem. 1, 228-237.
30. Holme, E., Kjellman, B. and Ronge, E. (1989) Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch. Dis. Child. 64, 1061-1064.
31. Selhub, J., Jacques, P. F., Bostom, A.G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J. and Rosenberg, I. H. (1995) Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332, 286-291.
32. Brönstrup, A., Kroesen, M. and Pietrzik, K. (1997) Multivitaminsupplementation in nutritiver Dosierung -Beeinflussung des Homocysteinspiegels von Männern und Frauen mittleren Alters. Europ. J. Nutr. 36, 112-113.
33. Dierkes, J. (1995) Vitamin requirements for the reduction of homocysteine blood levels in healthy young women. In: PhD-thesis, University of Bonn, Dr. Fleck, Giessen, Germany.
34. van den Berg, A., Riezler, R. and Naurath, H. J. (1993) Vitamin-B-Mangel im Alter. Münch. med. Wschr. 135, 506-509.
35. Guttormsen, A. B., Schneede, J., Ueland, P. M. and Refsum, H. (1996) Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am. J. Clin. Nutr. 63, 194-202.
36. 12 and folate deficiency. Eur. J. Haematol. 45, 143-149.
37. Landgren, F., Israelsson, B., Lindgren, A., Hultberg, B., Andersson, A. and Brattström, L. (1995) Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J. Intern. Med. 237, 381-388.
38. Robinson, K., Mayer, E.L., Miller, D.P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., Kutner, M., Topol, E. J. and Jacobsen, D. W. (1995) Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 92, 2825-2830.
39. 12-deficiency. J. Nutr. 126, 1266S-1272S.
40. Ubbink, J. B., Vermaak, W. J. H., Bennett, J. M., Becker, B. P. J., van Staden, D. A. and Bissbort, S. (1991) The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin. Wochenschr. 69, 527-534.